Skip to main content
SpringerLink
Log in

HIV-1 Genetic Diversity and Its Biological Significance

  • Chapter
  • First Online:
HIV and the Brain

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 909 Accesses

Abstract

Differences between HIV-1 genetic clades on pathogenicity, transmissibility, and other biological features often have been difficult to prove, due to multiple factors, including large intrasubtype diversity, frequent recombination, and methodological issues. In spite of the difficulties and limitations of the studies, evidence of some associations of HIV-1 clades with biological features has been found

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397:436–441.

    PubMed  CAS  Google Scholar 

  2. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000; 288:1789–1796.

    PubMed  CAS  Google Scholar 

  3. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK et al. HIV-1 nomenclature proposal. Science 2000; 288:55–56.

    PubMed  CAS  Google Scholar 

  4. Thomson MM, Pérez-Álvarez L, Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2:461–471.

    PubMed  CAS  Google Scholar 

  5. Kantor R. Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis 2006; 19:594–606.

    PubMed  CAS  Google Scholar 

  6. Brander C, Frahm N, Walker BD. The challenges of host and viral diversity in HIV vaccine design. Curr Opin Immunol 2006; 18:430–437.

    PubMed  CAS  Google Scholar 

  7. Gao F, Chen Y, Levy DN, Conway JA, Kepler TB, Hui H. Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious. J Virol 2004; 78:2426–2433.

    PubMed  CAS  Google Scholar 

  8. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM. Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 2004; 101:4204–4209.

    PubMed  CAS  Google Scholar 

  9. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271:1582–1586.

    PubMed  CAS  Google Scholar 

  10. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U et al. Multiply infected spleen cells in HIV patients. Nature 2002; 418:144.

    PubMed  CAS  Google Scholar 

  11. Shriner D, Rodrigo AG, Nickle DC, Mullins JI. Pervasive genomic recombination of HIV-1 in vivo. Genetics 2004; 167:1573–1583.

    PubMed  CAS  Google Scholar 

  12. Charpentier C, Nora T, Tenaillon O, Clavel F, Hance AJ. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol 2006; 80:2472–2482.

    PubMed  CAS  Google Scholar 

  13. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O’Sullivan KM et al. Selective escape from CD8 + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005; 79:13239–13249.

    PubMed  CAS  Google Scholar 

  14. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K et al. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 2006; 80:9519–9529.

    PubMed  CAS  Google Scholar 

  15. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X et al. Antibody neutralization and escape by HIV-1. Nature 2003; 422:307–312.

    PubMed  CAS  Google Scholar 

  16. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A 2005; 102:18514–18519.

    PubMed  CAS  Google Scholar 

  17. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001; 412:334–338.

    PubMed  CAS  Google Scholar 

  18. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282–289.

    PubMed  CAS  Google Scholar 

  19. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296:1439–1443.

    PubMed  CAS  Google Scholar 

  20. Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, Brunak S et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002; 76:8757–8768.

    PubMed  CAS  Google Scholar 

  21. Leslie A, Kavanagh D, Honeyborne I, Pfafferott K, Edwards C, Pillay T et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005; 201:891–902.

    PubMed  CAS  Google Scholar 

  22. Delwart E, Magierowska M, Royz M, Foley B, Peddada L, Smith R et al. Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 2002; 16:189–195.

    PubMed  CAS  Google Scholar 

  23. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999; 73:10489–10502.

    PubMed  CAS  Google Scholar 

  24. Thomson MM, Nájera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 2005; 7:210–224.

    PubMed  Google Scholar 

  25. Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F et al. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 2003; 310:254–266.

    PubMed  CAS  Google Scholar 

  26. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006; 313:523–526.

    PubMed  CAS  Google Scholar 

  27. Van Heuverswyn F, Li Y, Neel C, Bailes E, Keele BF, Liu W et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006; 444:164.

    PubMed  CAS  Google Scholar 

  28. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70:7013–7029.

    PubMed  CAS  Google Scholar 

  29. Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci USA 2007; 104:18566–18570.

    PubMed  CAS  Google Scholar 

  30. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W et al. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000; 74:10498–10507.

    PubMed  CAS  Google Scholar 

  31. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455:661–664.

    PubMed  CAS  Google Scholar 

  32. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998; 391:594–597.

    PubMed  CAS  Google Scholar 

  33. Rambaut A, Robertson DL, Pybus OG, Peeters M, Holmes EC. Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 2001; 410:1047–1048.

    PubMed  CAS  Google Scholar 

  34. Nájera R, Delgado E, Pérez-Álvarez L, Thomson MM. Genetic recombination and its role in the development of the HIV-1 pandemic. AIDS 2002; 16 Suppl 4:S3–S16.

    PubMed  Google Scholar 

  35. Sierra M, Thomson MM, Ríos M, Casado G, Castro RO, Delgado E et al. The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. Infect Genet Evol 2005; 5:209–217.

    PubMed  CAS  Google Scholar 

  36. Sierra M, Thomson MM, Posada D, Pérez L, Aragones C, González Z et al. Identification of 3 Phylogenetically Related HIV-1 BG intersubtype circulating recombinant forms in Cuba. J Acquir Immune Defic Syndr 2007; 45:151–160.

    PubMed  Google Scholar 

  37. Montavon C, Toure-Kane C, Liegeois F, Mpoudi E, Bourgeois A, Vergne L et al. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000; 23:363–374.

    PubMed  CAS  Google Scholar 

  38. Oelrichs RB, Crowe SM. The molecular epidemiology of HIV-1 in South and East Asia. Curr HIV Res 2003; 1:239–248.

    PubMed  CAS  Google Scholar 

  39. Saksena NK, Wang B, Steain M, Yang RG, Zhang LQ. Snapshot of HIV pathogenesis in China. Cell Res 2005; 15:953–961.

    PubMed  CAS  Google Scholar 

  40. Thomson MM, Villahermosa ML, Vázquez de Parga E, Cuevas MT, Delgado E, Manjón N et al. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. AIDS 2000; 14:897–899.

    PubMed  CAS  Google Scholar 

  41. Thomson MM, Delgado E, Herrero I, Villahermosa ML, Vázquez de Parga E, Cuevas MT et al. Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002; 83:107–119.

    PubMed  CAS  Google Scholar 

  42. Carr JK, Ávila M, Gómez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V et al. Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001; 15:F41–F47.

    PubMed  CAS  Google Scholar 

  43. Ou CY, Takebe Y, Weniger BG, Luo CC, Kalish ML, Auwanit W et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993; 341:1171–1174.

    PubMed  CAS  Google Scholar 

  44. McCutchan FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A et al. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992; 8:1887–1895.

    PubMed  CAS  Google Scholar 

  45. Dietrich U, Grez M, von Briesen H, Panhans B, Geissendorfer M, Kuhnel H et al. HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS 1993; 7:23–27.

    PubMed  CAS  Google Scholar 

  46. Novitsky VA, Montano MA, Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses 1998; 14:1079–1085.

    PubMed  CAS  Google Scholar 

  47. Nabatov AA, Kravchenko ON, Lyulchuk MG, Shcherbinskaya AM, Lukashov VV. Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res Hum Retroviruses 2002; 18:891–895.

    PubMed  Google Scholar 

  48. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006; 20:W13–W23.

    PubMed  Google Scholar 

  49. Op de Coul, van den Burg R, Asjo B, Goudsmit J, Cupsa A, Pascu R et al. Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. AIDS Res Hum Retroviruses 2000; 16:327–336.

    Google Scholar 

  50. Zetterberg V, Ustina V, Liitsola K, Zilmer K, Kalikova N, Sevastianova K et al. Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia. AIDS Res Hum Retroviruses 2004; 20:1148–1156.

    PubMed  CAS  Google Scholar 

  51. Ouedraogo-Traore R, Montavon C, Sanou T, Vidal N, Sangare L, Sanou I et al. CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso. AIDS 2003; 17:441–442.

    PubMed  Google Scholar 

  52. Marechal V, Jauvin V, Selekon B, Leal J, Pelembi P, Fikouma V et al. Increasing HIV type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from Central African Republic: a 2005 study. AIDS Res Hum Retroviruses 2006; 22:1036–1044.

    PubMed  CAS  Google Scholar 

  53. Arroyo MA, Hoelscher M, Sanders-Buell E, Herbinger KH, Samky E, Maboko L et al. HIV type 1 subtypes among blood donors in the Mbeya region of southwest Tanzania. AIDS Res Hum Retroviruses 2004; 20:895–901.

    PubMed  CAS  Google Scholar 

  54. Vidal N, Niyongabo T, Nduwimana J, Butel C, Ndayiragije A, Wakana J et al. HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. AIDS Res Hum Retroviruses 2007; 23:175–180.

    PubMed  CAS  Google Scholar 

  55. Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A et al. Identification of a genetic subcluster of HIV type 1 subtype C (C’) widespread in Ethiopia. AIDS Res Hum Retroviruses 2000; 16:1909–1914.

    PubMed  CAS  Google Scholar 

  56. Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P et al. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001; 75:10479–10487.

    PubMed  CAS  Google Scholar 

  57. Loemba H, Brenner B, Parniak MA, Ma’ayan S, Spira B, Moisi D et al. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob Agents Chemother 2002; 46:2087–2094.

    PubMed  CAS  Google Scholar 

  58. Vidal N, Mulanga C, Bazepeo SE, Mwamba JK, Tshimpaka JW, Kashi M et al. Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002. J Acquir Immune Defic Syndr 2005; 40:456–462.

    PubMed  Google Scholar 

  59. Hierholzer M, Graham RR, El K.I, Tasker S, Darwish M, Chapman GD et al. HIV type 1 strains from East and West Africa are intermixed in Sudan. AIDS Res Hum Retroviruses 2002; 18:1163–1166.

    PubMed  Google Scholar 

  60. Soares MA, de Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L et al. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 2003; 17:11–21.

    PubMed  CAS  Google Scholar 

  61. Soares EA, Martinez AM, Souza TM, Santos AF, Da H, V, Silveira J et al. HIV-1 subtype C dissemination in southern Brazil. AIDS 2005; 19 Suppl 4:S81–S86.

    PubMed  Google Scholar 

  62. Takebe Y, Motomura K, Tatsumi M, Lwin HH, Zaw M, Kusagawa S. High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination. AIDS 2003; 17:2077–2087.

    PubMed  Google Scholar 

  63. Saad MD, Al Jaufy A, Grahan RR, Nadai Y, Earhart KC, Sanchez JL et al. HIV type 1 strains common in Europe, Africa, and Asia cocirculate in Yemen. AIDS Res Hum Retroviruses 2005; 21:644–648.

    PubMed  CAS  Google Scholar 

  64. Su L, Graf M, Zhang Y, von Briesen H, Xing H, Kostler J et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B’) recombinant strain in China. J Virol 2000; 74:11367–11376.

    PubMed  CAS  Google Scholar 

  65. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, Chen J et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000; 74:11286–11295.

    PubMed  CAS  Google Scholar 

  66. Chen YM, Lan YC, Lai SF, Yang JY, Tsai SF, Kuo SH. HIV-1 CRF07_BC infections, injecting drug users, Taiwan. Emerg Infect Dis 2006; 12:703–705.

    PubMed  Google Scholar 

  67. Dowling WE, Kim B, Mason CJ, Wasunna KM, Alam U, Elson L et al. Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002; 16:1809–1820.

    PubMed  CAS  Google Scholar 

  68. Harris ME, Serwadda D, Sewankambo N, Kim B, Kigozi G, Kiwanuka N et al. Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate. AIDS Res Hum Retroviruses 2002; 18:1281–1290.

    PubMed  CAS  Google Scholar 

  69. Herbinger KH, Gerhardt M, Piyasirisilp S, Mloka D, Arroyo MA, Hoffmann O et al. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res Hum Retroviruses 2006; 22:599–606.

    PubMed  Google Scholar 

  70. Servais J, Lambert C, Karita E, Vanhove D, Fischer A, Baurith T et al. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda. AIDS Res Hum Retroviruses 2004; 20:279–283.

    PubMed  CAS  Google Scholar 

  71. Bobkov A, Cheingsong-Popov R, Selimova L, Ladnaya N, Kazennova E, Kravchenko A et al. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. AIDS Res Hum Retroviruses 1997; 13:1195–1201.

    PubMed  CAS  Google Scholar 

  72. Meloni ST, Kim B, Sankale JL, Hamel DJ, Tovanabutra S, Mboup S et al. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. J Virol 2004; 78:12438–12445.

    PubMed  CAS  Google Scholar 

  73. Meloni ST, Sankale JL, Hamel DJ, Eisen G, Gueye-Ndiaye A, Mboup S et al. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol 2004; 78:12455–12461.

    PubMed  CAS  Google Scholar 

  74. Niama FR, Toure-Kane C, Vidal N, Obengui P, Bikandou B, Ndoundou Nkodia MY et al. HIV-1 subtypes and recombinants in the Republic of Congo. Infect Genet Evol 2006; 6:337–343.

    PubMed  CAS  Google Scholar 

  75. Sarrami-Forooshani R, Das SR, Sabahi F, Adeli A, Esmaeili R, Wahren B et al. Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol 2006; 78:853–863.

    PubMed  CAS  Google Scholar 

  76. Khan S, Rai MA, Khanani MR, Khan MN, Ali SH. HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect Dis 2006; 6:164.

    PubMed  Google Scholar 

  77. Ciccozzi M, Gori C, Boros S, Ruiz-Álvarez MJ, Harxhi A, Dervishi M et al. Molecular diversity of HIV in Albania. J Infect Dis 2005; 192:475–479.

    PubMed  CAS  Google Scholar 

  78. Paraskevis D, Magiorkinis E, Katsoulidou A, Hatzitheodorou E, Antoniadou A, Papadopoulos A et al. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Res 2005; 112:115–122.

    PubMed  CAS  Google Scholar 

  79. Thomson MM, Casado G, Posada D, Sierra M, Nájera R. Identification of a novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. AIDS 2005; 19:1155–1163.

    PubMed  Google Scholar 

  80. Pérez L, Thomson MM, Bleda MJ, Aragonés C, González Z, Pérez J et al. HIV Type 1 molecular epidemiology in cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms. AIDS Res Hum Retroviruses 2006; 22:724–733.

    PubMed  Google Scholar 

  81. Subbarao S, Vanichseni S, Hu DJ, Kitayaporn D, Choopanya K, Raktham S et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses 2000; 16:699–707.

    PubMed  CAS  Google Scholar 

  82. Motomura K, Kusagawa S, Lwin HH, Thwe M, Kato K, Oishi K et al. Different subtype distributions in two cities in Myanmar: evidence for independent clusters of HIV-1 transmission. AIDS 2003; 17:633–636.

    PubMed  Google Scholar 

  83. Yang R, Xia X, Kusagawa S, Zhang C, Ben K, Takebe Y. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 2002; 16:1401–1407.

    PubMed  Google Scholar 

  84. 84.Tee KK, Li XJ, Nohtomi K, Ng KP, Kamarulzaman A, Takebe Y. Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr 2006; 43:523–529.

    PubMed  CAS  Google Scholar 

  85. Su B, Liu L, Wang F, Gui X, Zhao M, Tien P et al. HIV-1 subtype B’ dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:2515–2520.

    PubMed  Google Scholar 

  86. Kang MR, Cho YK, Chun J, Kim YB, Lee I, Lee HJ et al. Phylogenetic analysis of the nef gene reveals a distinctive monophyletic clade in Korean HIV-1 cases. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:58–68.

    PubMed  CAS  Google Scholar 

  87. Bello G, Eyer-Silva WA, Couto-Fernandez JC, Guimaraes ML, Chequer-Fernandez SL, Teixeira SL et al. Demographic history of HIV-1 subtypes B and F in Brazil. Infect Genet Evol 2007; 7:263–270.

    PubMed  CAS  Google Scholar 

  88. Morgado MG, Sabino EC, Shpaer EG, Bongertz V, Brigido L, Guimaraes MD et al. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses 1994; 10:569–576.

    PubMed  CAS  Google Scholar 

  89. Peeters M, Esu-Williams E, Vergne L, Montavon C, Mulanga-Kabeya C, Harry T et al. Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. AIDS Res Hum Retroviruses 2000; 16:315–325.

    PubMed  CAS  Google Scholar 

  90. Esteves A, Parreira R, Venenno T, Franco M, Piedade J, Germano dS et al. Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002; 18:313–325.

    PubMed  CAS  Google Scholar 

  91. Esteves A, Parreira R, Piedade J, Venenno T, Franco M, Germano dS et al. Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal. AIDS Res Hum Retroviruses 2003; 19:511–517.

    PubMed  CAS  Google Scholar 

  92. Thomson MM, Delgado E, Manjon N, Ocampo A, Villahermosa ML, Marino A et al. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 2001; 15:509–516.

    PubMed  CAS  Google Scholar 

  93. Delgado E, Thomson MM, Villahermosa ML, Sierra M, Ocampo A, Miralles C et al. Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J Acquir Immune Defic Syndr 2002; 29:536–543.

    PubMed  CAS  Google Scholar 

  94. Vidal N, Koyalta D, Richard V, Lechiche C, Ndinaromtan T, Djimasngar A et al. High genetic diversity of HIV-1 strains in Chad, West Central Africa. J Acquir Immune Defic Syndr 2003; 33:239–246.

    PubMed  Google Scholar 

  95. Yu XF, Chen J, Shao Y, Beyrer C, Liu B, Wang Z et al. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr 1999; 22:180–188.

    PubMed  CAS  Google Scholar 

  96. Zhang Y, Lu L, Ba L, Liu L, Yang L, Jia M et al. Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006; 3:e443.

    PubMed  Google Scholar 

  97. Liitsola K, Ristola M, Holmstrom P, Salminen M, Brummer-Korvenkontio H, Simola S et al. An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population. AIDS 2000; 14:2613–2615.

    PubMed  CAS  Google Scholar 

  98. Nyambi P, Heyndrickx L, Vereecken K, Burda S, De Houwer K, Coppens S et al. Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 2002; 16:295–296.

    PubMed  Google Scholar 

  99. Ortiz M, Sánchez I, González MP, León MI, Abeso N, Asumu E et al. Molecular epidemiology of HIV type 1 subtypes in Equatorial Guinea. AIDS Res Hum Retroviruses 2001; 17:851–855.

    PubMed  CAS  Google Scholar 

  100. Peeters M, Toure-Kane C, Nkengasong JN. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials. AIDS 2003; 17:2547–2560.

    PubMed  Google Scholar 

  101. Rousseau CM, Learn GH, Bhattacharya T, Nickle DC, Heckerman D, Chetty S et al. Extensive intrasubtype recombination in South african human immunodeficiency virus type 1 subtype C infections. J Virol 2007; 81:4492–4500.

    PubMed  CAS  Google Scholar 

  102. Tatt ID, Barlow KL, Clewley JP, Gill ON, Parry JV. Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997–2000. J Acquir Immune Defic Syndr 2004; 36:1092–1099.

    PubMed  Google Scholar 

  103. Fleury H, Recordon-Pinson P, Caumont A, Faure M, Roques P, Plantier JC et al. HIV type 1 diversity in France, 1999–2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs. AIDS Res Hum Retroviruses 2003; 19:41–47.

    PubMed  CAS  Google Scholar 

  104. Snoeck J, Van Laethem K, Hermans P, Van Wijngaerden E, Derdelinckx I, Schrooten Y et al. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983–2001. J Acquir Immune Defic Syndr 2004; 35:279–285.

    PubMed  Google Scholar 

  105. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997; 71:8657–8665.

    PubMed  CAS  Google Scholar 

  106. Montano MA, Nixon CP, Essex M. Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol 1998; 72:8446–8452.

    PubMed  CAS  Google Scholar 

  107. Montano MA, Nixon CP, Ndung’u T, Bussmann H, Novitsky VA, Dickman D et al. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis 2000; 181:76–81.

    PubMed  CAS  Google Scholar 

  108. Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J Virol 2002; 76:11091–11103.

    PubMed  CAS  Google Scholar 

  109. Lemieux AM, Pare ME, Audet B, Legault E, Lefort S, Boucher N et al. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region. J Biol Chem 2004; 279:52949–52960.

    PubMed  CAS  Google Scholar 

  110. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000; 74:3740–3751.

    PubMed  CAS  Google Scholar 

  111. van Opijnen T, Jeeninga RE, Boerlijst MC, Pollakis GP, Zetterberg V, Salminen M et al. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J Virol 2004; 78:3675–3683.

    PubMed  CAS  Google Scholar 

  112. Verhoef K, Sanders RW, Fontaine V, Kitajima S, Berkhout B. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol 1999; 73:1331–1340.

    PubMed  CAS  Google Scholar 

  113. Roof P, Ricci M, Genin P, Montano MA, Essex M, Wainberg MA et al. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 2002; 296:77–83.

    PubMed  CAS  Google Scholar 

  114. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors—central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20:111–126.

    PubMed  CAS  Google Scholar 

  115. Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988; 62:2026–2032.

    PubMed  CAS  Google Scholar 

  116. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature 1996; 383:768.

    PubMed  CAS  Google Scholar 

  117. Peeters M, Vincent R, Perret JL, Lasky M, Patrel D, Liegeois F et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:115–121.

    PubMed  CAS  Google Scholar 

  118. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998; 241:181–188.

    PubMed  CAS  Google Scholar 

  119. Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G et al. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999; 13:1305–1311.

    PubMed  CAS  Google Scholar 

  120. Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol 1999; 73:6271–6281.

    PubMed  CAS  Google Scholar 

  121. Cecilia D, Kulkarni SS, Tripathy SP, Gangakhedkar RR, Paranjape RS, Gadkari DA. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 2000; 271:253–258.

    PubMed  CAS  Google Scholar 

  122. Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, Katzenstein DA. High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003; 77:7682–7688.

    PubMed  CAS  Google Scholar 

  123. Monteiro JP, Ferraro GA, Oliveira T, Goldani LZ, Kashima S, Alcantara LC et al. Genetic and biologic characterization of HIV type 1 subtype C isolates from south Brazil. AIDS Res Hum Retroviruses 2007; 23:135–143.

    PubMed  CAS  Google Scholar 

  124. Pérez-Álvarez L, Delgado E, Villahermosa ML, Cuevas MT, García V, Vázquez de Parga et al. Biological characteristics of newly described HIV-1 BG recombinants in Spanish individuals. AIDS 2002; 16:669–672.

    PubMed  Google Scholar 

  125. Yu XF, Wang Z, Beyrer C, Celentano DD, Khamboonruang C, Allen E et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J Virol 1995; 69:4649–4655.

    PubMed  CAS  Google Scholar 

  126. Kato K, Sato H, Takebe Y. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. J Virol 1999; 73:5520–5526.

    PubMed  CAS  Google Scholar 

  127. Holm-Hansen C, Baan E, Asjo B, Pascu FR, Goudsmit J, De Jong JJ. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region. AIDS Res Hum Retroviruses 2000; 16:867–870.

    PubMed  CAS  Google Scholar 

  128. Jensen MA, Coetzer M, van’t Wout AB, Morris L, Mullins JI. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006; 80:4698–4704.

    PubMed  CAS  Google Scholar 

  129. Coetzer M, Cilliers T, Ping LH, Swanstrom R, Morris L. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. Virology 2006; 356:95–105.

    PubMed  CAS  Google Scholar 

  130. Papuashvili MN, Novokhatsky AS, Shcherbakova TI. Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe. Infect Genet Evol 2005; 5:45–53.

    PubMed  CAS  Google Scholar 

  131. Desfosses Y, Solis M, Sun Q, Grandvaux N, Van Lint C, Burny A et al. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J Virol 2005; 79:9180–9191.

    PubMed  CAS  Google Scholar 

  132. Kurosu T, Mukai T, Komoto S, Ibrahim MS, Li YG, Kobayashi T et al. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E. Microbiol Immunol 2002; 46:787–799.

    PubMed  CAS  Google Scholar 

  133. Ranjbar S, Rajsbaum R, Goldfeld AE. Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus. J Immunol 2006; 176:4182–4190.

    PubMed  CAS  Google Scholar 

  134. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R et al. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 1992; 66:7159–7167.

    PubMed  CAS  Google Scholar 

  135. Ranjbar S, Tsytsykova AV, Lee SK, Rajsbaum R, Falvo JV, Lieberman J et al. NFAT5 Regulates HIV-1 in Primary Monocytes via a Highly Conserved Long Terminal Repeat Site. PLoS Pathog 2006; 2:e130.

    PubMed  Google Scholar 

  136. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A 1998; 95:3117–3121.

    PubMed  CAS  Google Scholar 

  137. Weiss JM, Nath A, Major EO, Berman JW. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 1999; 163:2953–2959.

    PubMed  CAS  Google Scholar 

  138. Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B et al. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 2003; 24:224–237.

    PubMed  CAS  Google Scholar 

  139. Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M et al. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004; 78:2586–2590.

    PubMed  CAS  Google Scholar 

  140. Campbell GR, Watkins JD, Singh KK, Loret EP, Spector SA. The human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol 2007; 81:5919–5928.

    PubMed  CAS  Google Scholar 

  141. Satishchandra P, Nalini A, Gourie-Devi M, Khanna N, Santosh V, Ravi V et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989–96). Indian J Med Res 2000; 111:14–23.

    PubMed  CAS  Google Scholar 

  142. Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S et al. Neurological manifestations of HIV disease. J Assoc Physicians India 2001; 49:343–348.

    PubMed  CAS  Google Scholar 

  143. Deshpande AK, Patnaik MM. Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study. MedGenMed 2005; 7:2.

    PubMed  Google Scholar 

  144. Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S et al. Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 2006; 12:424–430.

    PubMed  Google Scholar 

  145. Riedel D, Ghate M, Nene M, Paranjape R, Mehendale S, Bollinger R et al. Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol 2006; 12:34–38.

    PubMed  CAS  Google Scholar 

  146. Modi G, Hari K, Modi M, Mochan A. The frequency and profile of neurology in black South African HIV infected (clade C) patients – a hospital-based prospective audit. J Neurol Sci 2007; 254:60–64.

    PubMed  Google Scholar 

  147. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, Quiñones-Mateu ME et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003; 77:1021–1038.

    PubMed  CAS  Google Scholar 

  148. Arien KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005; 79:8979–8990.

    PubMed  CAS  Google Scholar 

  149. Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M et al. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 2006; 42:843–852.

    PubMed  Google Scholar 

  150. Glynn JR, Sonnenberg P, Nelson G, Bester A, Shearer S, Murray J. Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up. AIDS 2007; 21:625–632.

    PubMed  Google Scholar 

  151. Konings FA, Burda ST, Urbanski MM, Zhong P, Nadas A, Nyambi PN. Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. J Med Virol 2006; 78:523–534.

    PubMed  CAS  Google Scholar 

  152. Njai HF, Gali Y, Vanham G, Clybergh C, Jennes W, Vidal N et al. The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006; 3:40.

    PubMed  Google Scholar 

  153. Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E et al. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr 2002; 30:463–470.

    PubMed  Google Scholar 

  154. Gray CM, Williamson C, Bredell H, Puren A, Xia X, Filter R et al. Viral dynamics and CD4 + T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses 2005; 21:285–291.

    PubMed  CAS  Google Scholar 

  155. Hu DJ, Vanichseni S, Mastro TD, Raktham S, Young NL, Mock PA et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001; 15:683–691.

    PubMed  CAS  Google Scholar 

  156. Kivela PS, Krol A, Salminen MO, Geskus RB, Suni JI, Anttila VJ et al. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland. Scand J Infect Dis 2005; 37:276–283.

    PubMed  Google Scholar 

  157. Fischetti L, Opare-Sem O, Candotti D, Lee H, Allain JP. Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS 2004; 18:1208–1210.

    PubMed  Google Scholar 

  158. Sarr AD, Eisen G, Gueye-Ndiaye A, Mullins C, Traore I, Dia MC et al. Viral dynamics of primary HIV-1 infection in Senegal, West Africa. J Infect Dis 2005; 191:1460–1467.

    PubMed  CAS  Google Scholar 

  159. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587–1590.

    PubMed  CAS  Google Scholar 

  160. Popper SJ, Sarr AD, Travers KU, Gueye-Ndiaye A, Mboup S, Essex ME et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180:1116–1121.

    PubMed  CAS  Google Scholar 

  161. Andersson S, Norrgren H, da Silva Z, Biague A, Bamba S, Kwok S et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286–3293.

    PubMed  CAS  Google Scholar 

  162. Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS 1999; 13:901–907.

    PubMed  CAS  Google Scholar 

  163. Del Amo J, Petruckevitch A, Phillips A, Johnson AM, Stephenson J, Desmond N et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998; 12:1203–1209.

    PubMed  CAS  Google Scholar 

  164. Galai N, Kalinkovich A, Burstein R, Vlahov D, Bentwich Z. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel. Lancet 1997; 349:180–181.

    PubMed  CAS  Google Scholar 

  165. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68–73.

    PubMed  CAS  Google Scholar 

  166. Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M et al. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J Infect Dis 2002; 186:486–492.

    PubMed  Google Scholar 

  167. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244–1250.

    PubMed  Google Scholar 

  168. 168.Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F et al. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008; 197:707–713.

    PubMed  Google Scholar 

  169. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L et al. HIV-1 Subtype D Infection Is Associated with Faster Disease Progression than Subtype A in Spite of Similar Plasma HIV-1 Loads. J Infect Dis 2007; 195:1177–1180.

    PubMed  Google Scholar 

  170. Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J, Lule DB et al. Relation between chemokine receptor use, disease stage, and HIV-1 Subtypes A and D: results from a rural Ugandan Cohort. J Acquir Immune Defic Syndr 2007; 45:28–33.

    PubMed  CAS  Google Scholar 

  171. Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G et al. Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012). J Acquir Immune Defic Syndr 2002; 31:327–330.

    PubMed  Google Scholar 

  172. Santoro-Lopes G, Harrison LH, Tavares MD, Xexeo A, Dos Santos AC, Schechter M. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br? AIDS Res Hum Retroviruses 2000; 16:953–958.

    PubMed  CAS  Google Scholar 

  173. Casseb J, Komninakis S, Abdalla L, Brigido LF, Rodrigues R, Araujo F et al. HIV disease progression: is the Brazilian variant subtype B’ (GWGR motif) less pathogenic than US/European subtype B (GPGR). Int J Infect Dis 2002; 6:164–169.

    PubMed  Google Scholar 

  174. de Brito A, Komninakis SC, Novoa P, de Oliveira RM, Fonseca LA, Duarte AJ et al. Women infected with HIV type 1 Brazilian variant, subtype B (B’-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif). Clin Infect Dis 2006; 43:1476–1481.

    PubMed  Google Scholar 

  175. Kanki PJ, Travers KU, Mboup S, Hsieh CC, Marlink RG, Gueye-Ndiaye A et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943–946.

    PubMed  CAS  Google Scholar 

  176. Gilbert PB, McKeague IW, Eisen G, Mullins C, Gueye-Ndiaye A, Mboup S et al. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med 2003; 22:573–593.

    PubMed  Google Scholar 

  177. Adjorlolo-Johnson G, De Cock KM, Ekpini E, Vetter KM, Sibailly T, Brattegaard K et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462–466.

    PubMed  CAS  Google Scholar 

  178. O’Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000; 14:441–448.

    PubMed  Google Scholar 

  179. Mastro TD, Satten GA, Nopkesorn T, Sangkharomya S, Longini IM, Jr. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 1994; 343:204–207.

    PubMed  CAS  Google Scholar 

  180. Nelson KE, Rungruengthanakit K, Margolick J, Suriyanon V, Niyomthai S, de Boer MA et al. High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in Northern Thailand: role of sexually transmitted diseases and immune compromise. J Infect Dis 1999; 180:337–343.

    PubMed  CAS  Google Scholar 

  181. Mastro TD, Vincenzi, I.de Probabilities of sexual HIV-1 transmission. AIDS 1996; 10 Suppl A:S75–S82.

    PubMed  Google Scholar 

  182. Soto-Ramírez LE, Renjifo B, McLane MF, Marlink R, O’Hara C, Sutthent R et al. HIV-1 Langerhans’ cell tropism associated with heterosexual transmission of HIV. Science 1996; 271:1291–1293.

    PubMed  Google Scholar 

  183. Pope M, Frankel SS, Mascola JR, Trkola A, Isdell F, Birx DL et al. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J Virol 1997; 71:8001–8007.

    PubMed  CAS  Google Scholar 

  184. Dittmar MT, Simmons G, Hibbitts S, O’Hare M, Louisirirotchanakul S, Beddows S et al. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol 1997; 71:8008–8013.

    PubMed  CAS  Google Scholar 

  185. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149–1153.

    PubMed  CAS  Google Scholar 

  186. John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S et al. Subtype C Is associated with increased vaginal shedding of HIV-1. J Infect Dis 2005; 192:492–496.

    PubMed  Google Scholar 

  187. Hudgens MG, Longini IM, Jr., Vanichseni S, Hu DJ, Kitayaporn D, Mock PA et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol 2002; 155:159–168.

    PubMed  Google Scholar 

  188. Yang C, Li M, Newman RD, Shi YP, Ayisi J, van Eijk AM et al. Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 2003; 17:1667–1674.

    PubMed  Google Scholar 

  189. Murray MC, Embree JE, Ramdahin SG, Anzala AO, Njenga S, Plummer FA. Effect of human immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1. J Infect Dis 2000; 181:746–749.

    PubMed  CAS  Google Scholar 

  190. Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D et al. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol 2001; 4:16–25.

    PubMed  CAS  Google Scholar 

  191. Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D et al. HIV-1 LTR subtype and perinatal transmission. Virology 2001; 287:261–265.

    PubMed  CAS  Google Scholar 

  192. Martinez AM, Hora VP, Santos AL, Mendoza-Sassi R, Von Groll A, Soares EA et al. Determinants of HIV-1 mother-to-child transmission in Southern Brazil. An Acad Bras Cienc 2006; 78:113–121.

    PubMed  Google Scholar 

  193. Tapia N, Franco S, Puig-Basagoiti F, Menendez C, Alonso PL, Mshinda H et al. Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission. J Gen Virol 2003; 84:607–613.

    PubMed  CAS  Google Scholar 

  194. Fischetti L, Danso K, Dompreh A, Addo V, Haaheim L, Allain JP. Vertical transmission of HIV in Ghanaian women diagnosed in cord blood and post-natal samples. J Med Virol 2005; 77:351–359.

    PubMed  Google Scholar 

  195. Renjifo B, Chung M, Gilbert P, Mwakagile D, Msamanga G, Fawzi W et al. In-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes. Virology 2003; 307:278–282.

    PubMed  CAS  Google Scholar 

  196. Koulinska IN, Villamor E, Msamanga G, Fawzi W, Blackard J, Renjifo B et al. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Res 2006; 120:191–198.

    PubMed  CAS  Google Scholar 

  197. Travers SA, Clewley JP, Glynn JR, Fine PE, Crampin AC, Sibande F et al. Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1. J Virol 2004; 78:10501–10506.

    PubMed  CAS  Google Scholar 

  198. Fiore JR, Zhang YJ, Bjorndal A, Di Stefano M, Angarano G, Pastore G et al. Biological correlates of HIV-1 heterosexual transmission. AIDS 1997; 11:1089–1094.

    PubMed  CAS  Google Scholar 

  199. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344:720–725.

    PubMed  CAS  Google Scholar 

  200. Geldmacher C, Currier JR, Gerhardt M, Haule A, Maboko L, Birx D et al. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype. AIDS 2007; 21:135–143.

    PubMed  CAS  Google Scholar 

  201. McKinnon LR, Ball TB, Kimani J, Wachihi C, Matu L, Luo M et al. Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J Acquir Immune Defic Syndr 2005; 40:245–249.

    PubMed  Google Scholar 

  202. Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005; 191:1427–1434.

    PubMed  CAS  Google Scholar 

  203. Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C et al. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004; 78:13232–13252.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain

    Michael M. Thomson

Authors
  1. Michael M. Thomson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael M. Thomson .

Editor information

Editors and Affiliations

  1. Department of Psychology Behavioral Neuroscience, University of Missouri – St. Louis, St. Louis, U.S.A.

    Robert H. Paul PhD

  2. Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A.

    Ned Charlton Sacktor

  3. Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, U.S.A.

    Victor Valcour

  4. Memory and Aging Center Department of Neurology, UCSF, San Francisco, CA, U.S.A.

    Victor Valcour

  5. The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI, U.S.A.

    Karen Tokie Tashima

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Thomson, M.M. (2009). HIV-1 Genetic Diversity and Its Biological Significance. In: Paul, R., Sacktor, N., Valcour, V., Tashima, K. (eds) HIV and the Brain. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-434-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-434-6_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-934115-08-4

  • Online ISBN: 978-1-59745-434-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation